Mr Gove ministerial statement followed the brouhaha last week when MP's voted against transferring the EU protocol on animal sentience into UK law.
However, Conservative MP Zac Goldsmith said in a tweet that the vote had not been about whether or not MPs recognise animals as sentient, but about the best legal framework within which to deliver high standards of animal welfare. Rachel Maclean, MP for Redditch also weighed in, saying that the idea that MPs had voted against animals as sentient beings was 'fake news'.
Mr Gove's ministerial statement reads as follows:
"This Government is committed to the very highest standards of animal welfare. As the Prime Minister has set out, we will make the United Kingdom a world leader in the care and protection of animals.
It has been suggested that the vote last week on New Clause 30 of the EU Withdrawal Bill somehow signalled a weakening in the protection of animals - that is wrong. Voting against the amendment was not a vote against the idea that animals are sentient and feel pain - that is a misconception.
Ministers explained on the floor of the house that this Government’s policies on animal welfare are driven by our recognition that animals are indeed sentient beings and we are acting energetically to reduce the risk of harm to animals – whether on farms or in the wild. The vote against New Clause 30 was the rejection of a faulty amendment, which would not have achieved its stated aims of providing appropriate protection for animals.
The Prime Minister has made clear that we will strengthen our animal welfare rules. This government will ensure that any necessary changes required to UK law are made in a rigorous and comprehensive way to ensure animal sentience is recognised after we leave the EU. The Withdrawal Bill is not the right place to address this, however we are considering the right legislative vehicle.
We are already proposing primary legislation to increase maximum sentences for animal cruelty from six months to five years, and the creation of a new statutory, independent body to uphold environmental standards.
The current EU instrument – Article 13 – has not delivered the progress we want to see. It does not have direct effect in law – in practice its effect is very unclear and it has failed to prevent practices across the EU which are cruel and painful to animals.
In contrast, here in the UK, we are improving animal welfare standards without EU input and beyond the scope of Article 13. We are making CCTV mandatory in all slaughterhouses – a requirement which goes above and beyond any EU rule. We will consult on draft legislation to jail animal abusers for up to five years – more than almost every other European nation. We propose combatting elephant poaching with a ban on the ivory trade which is more comprehensive than anywhere else in Europe. Our ban on microbeads which harm marine animals has been welcomed by Greenpeace as “the strongest in the world”, and is certainly the strongest in Europe.
Once we have left the EU there is even more we could do. EU rules prevent us from restricting or banning the live export of animals for slaughter. EU rules also restrict us from cracking down on puppy smuggling or banning the import of puppies under 6 months. Article 13 has not stopped any of these practices – but leaving the EU gives us the chance to do much better. We hope to say more in these areas next year.
This government will continue to promote and enhance animal welfare, both now and after we have left the EU."
Photo: Curious cattle on farmland in Cornwall UK. Shzphoto/Shutterstock
Henry Schein, Inc. has announced the acquisition of Veterinary Instrumentation, the supplier of surgical instruments and implants to veterinary surgeons in the United Kingdom.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein said: "We are delighted to welcome this highly regarded company to the Henry Schein family, and very pleased that founder John Lapish and Managing Director Steve Fletcher will continue to drive the business forward.
"The success of Veterinary Instrumentation closely parallels the cornerstones of Henry Schein, including a deep understanding of customer needs, innovative solutions, superior product quality and customer service, and a trusted advisory relationship with our customers. Reinforcing our existing animal health business in the U.K., we look forward to strengthening our relationship with veterinary customers in this region, and bringing the Veterinary Instrumentation product portfolio of high-quality surgical specialties to a growing number of veterinarians across Europe, the United States and Australasia."
Veterinary Instrumentation was founded by John Lapish in 1986 in Sheffield, England, where the business and distribution operations are currently conducted from a single facility. Working as a small animal orthopaedic surgeon in the late 1970s, Mr. Lapish began designing and developing a range of instruments specifically for veterinary surgery, initially for his own use. As requests for these products increased, the market need became clear and Veterinary Instrumentation was formed, in particular to meet the needs of orthopaedic surgeons focused on small animals.
Mr Lapish said: "We look forward to contributing to the continued growth and success of a leading supplier of companion animal health products and services in the United Kingdom and to becoming part of a global leader in the distribution of health care products and services.
"The expertise that we bring in the area of veterinary surgical instruments will complement Henry Schein's broad offering, and our customers will benefit greatly from the global resources of a company that has quickly become an animal health care product and service leader on three continents."
With approximately 60 percent of sales in the U.K., and the balance split fairly evenly between Europe and the rest of the world, Veterinary Instrumentation has 20 employees, including a team of eight Veterinary Technicians who advise customers on the most appropriate procedures and instrumentation.
Veterinary Instrumentation sales for the 12 months ended September 30, 2011 were approximately £6.7 million ($10.8 million). Financial terms of the transaction were not disclosed.
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
Betafuse contains 5mg/g fusidic acid and 1mg/g betamethasone gel. It is available in 15g and 30g polyfoil tubes, designed to reduce the likelihood of splitting and loss of product during use.
Richard Palmer, Global Head of Sales and Marketing at Norbrook said: "We are delighted to be bringing this new product to the market in 16 European countries including the UK and Ireland. Betafuse is particularly exciting for us as we have improved the packaging and we have extended the 'in use' shelf life to eight weeks in comparison to six weeks for the pharmaceutically equivalent pioneer.
"This continued investment in our companion animal portfolio comes on the back of our recent launch in the US of Carprofen Chewable Tablets, an anti-inflammatory also for dogs. Our £40 million multi-year investment programme which we are currently engaged in, includes a significant emphasis on new product development including investment in R&D and our facilities infrastructure."
Lizzie Barnard, UK Product Manager added: "Betafuse offers the prescribing veterinary surgeon greater choice and it complements our existing companion animal skin care portfolio which includes Marbodex, a treatment for otitis externa in dogs.
"“Product support material is available and includes a guide for dog owners on how to apply Betafuse simply and effectively. This leaflet is available by contacting your territory manager or by downloading it from our website."
For more information, visit: https://www.norbrook.com/
The practice has also strengthened its surgery services with the appointment of Dr Delphine Holopherne-Doran, European Specialist in Veterinary Anaesthesia and Analgesia.
Ivan graduated from Bristol University in 1997. He worked in Hertfordshire before completing a surgical residency under the tutelage of Professor Peter Holt at Bristol University. Ivan has worked in referral centres in the UK and France. He is an RCVS Diplomate in Small Animal Soft Tissue Surgery and a Recognised Specialist in Small Animal Soft Tissue Surgery. Before joining Highcroft, he spent six years working as a senior staff surgeon at Bristol University.
Ed graduated from the Royal Veterinary College (RVC) in 1996. He worked in a mixed practice in Buckinghamshire before undertaking training positions at the RVC, University of Liverpool and the University of Cambridge. He passed the specialist Diploma examinations of the European College of Veterinary Surgeons in 2003. He has previously been a senior surgeon and member of academic staff at the University of Bristol and has worked in private referral practice.
Delphine graduated from Maisons-Alfort (Paris) Vet School in 1998. After working as an equine vet, where she developed an interest in veterinary anaesthesia and analgesia, she returned to vet school in Nantes where she ran the Anaesthesia department for 11 years. During this time, she gained a Master’s degree and a PhD in cardiovascular pharmacology and completed a residency, gaining European board certification in anaesthesia and analgesia, which led her to visit and train in universities around the world.
Highcroft Hospital Director Mr Chris Mayers said: “Ivan and Ed bring a wealth of experience in urinary tract surgery and, in particular, in urinary incontinence to Highcroft. The most common presentations are juvenile animals with ectopic ureters or urethral sphincter mechanism incompetence (post-spay incontinence). Ivan and Ed offer an innovative, minimally-invasive procedure using cystoscopically-guided laser ablation for patients with intramural ectopic ureters. Interventional radiology techniques are also a major interest for the team providing new, minimally-invasive solutions for intrahepatic shunts. The two surgeons have firmly adopted Subcutaneous Ureteral Bypass Systems (SUBS) in treating cats with ureteral obstruction, typically caused by calculi.
"Delphine adds world-class expertise in anaesthesia and analgesia and is already making a huge contribution to our hospital. With a high degree of skill in managing cardiovascular physiology and pharmacology cases, Delphine boosts our ability to support highly challenging and complex patients. Her knowledge of the use of local and region blocks for treating highly challenging pain cases and the anaesthesia of complex cardiovascular patients provides outstanding care for patients and promotes the highest standard in analgesia."
Highcroft Veterinary Group is based at 615 Wells Road, Whitchurch, Bristol and can be contacted on 01275 832410.
The company says the new product has been launched in response to demand from UK equine veterinary surgeons specialising in dentistry
Hexarinse for Horses is presented as a palatable, mint-flavoured, ready-to-use formulation in a five litre container.
Virbac says the antibacterial action of chlorhexidine supports the maintenance of oral health after dental procedures and may aid the management of periodontal disease, oral inflammation and the management of peripheral caries.
For further information, speak to your local Virbac territory manager or contact Virbac Limited on: 01359 243243 or enquiries@virbac.co.uk.
The Vital Support launch includes a new Feline Renal Multipack to support cats with chronic kidney disease and loss of appetite. The multipack contains four wet pouches with different aromatic profiles to help stimulate decreased appetite and deliver optimum food acceptance and compliance. Multipacks will be available from October 2020.
Royal Canin has also introduced new Early Renal diets to help support the kidneys at early stages of renal insufficiency, and will be discontinuing its Feline VCN Senior Consult Stage 2 diets.
The company is also introducing two new diets for small dogs: Renal Small Dogs to support small breed dogs in the more advanced stages of chronic renal insufficiency, and Mobility C2P+ Small Dogs, formulated to support healthy joint function.
Other changes include a switch to 100% sustainably sourced salmon in its renal wet pouches, and to vegetable sources of glucosamine, instead of shellfish.
For more information, visit: https://vetportal.royalcanin.co.uk, speak to a member of the veterinary pillar team or contact the Nutritional Helpline.
The company says that the Phillips tuberculin gun is easier to use, clean and maintain than the most commonly used device, and it also offers practices doing government TB testing work the opportunity to make substantial savings on the cost of consumables.
Dave Gilbert MRCVS, director with Dairy Insight said: "There is no official requirement to use a single make of gun for TB testing work, so with tightening margins for work in this arena it makes sense for practices to explore valid cost-saving options.
"Having trialled this NJ Phillips gun over the last 12 months in our own farm practice we’ve been very pleased with it, particularly when it comes to changing needles. I’ve always found this process fiddly, especially when you have cold hands. We’ve also made substantial savings on consumables, which are over 70p per needle cheaper for the V-Grip."
The V-Grip is precision engineered for optimum dosing accuracy and comes with a visible chamber, to help ensure correct administration of tuberculin.
For more information, contact Dairy Insight at: info@dairyinsight.co.uk
Hannah, who graduated from the RVC in 2015, was nominated for her dedication to excelling in first-opinion practice through her farm, small animal and equine work as a mixed animal vet in Aberystwyth.
She was selected from a field of more than 100 entrants by the award judges BVA President Malcolm Morley, President of the Royal College of Veterinary Surgeons (RCVS) Melissa Donald, Professor the Lord Trees, Zoetis National Veterinary Manager Jonny Lambert and last year’s winner of the award, Alex Davies.
Hannah said: “This is fantastic! I’m so pleased to accept this award.
"I want to say a huge thanks to my practice for giving me the freedom to explore my passions and enabling me to work with a wide of range of species.
"I want to particularly mention my mentors Dafydd, Phil and Kate, who inspired me to focus on what I love.”
BVA President Malcolm Morley said: “Hannah’s incredible enthusiasm and passion for her work as a mixed-practice vet really made her stand-out to us.
"She is excelling in her work across species, which is challenging enough, but she’s also doing it at a high level.
"It is great to recognise the contribution that Hannah and other first-opinion vets make to our profession."
The new clinic will be based in Uttoxeter and have an in-house 1.5T MRI, 32-slice CT, and three purpose-built theatres.
Building work has started and clinic is now recruiting for orthopaedic surgery Specialists, neurology Specialists and experienced veterinary nurses.
Mark Lowrie, RCVS and EBVS European Specialist in Veterinary Neurology (pictured), will lead the new site day-to-day once up and running.
He said: “Our ethos is simple: we aspire to be the place that vets take their own pets.
"By focusing on responsive communication, exceptional clinical standards, and fair pricing, we aim to build trust with both veterinary professionals and clients.
"And for those who join our team, we are committed to creating a supportive and positive environment where everyone can thrive and grow."
“This is a rare chance to be part of something special from day one, to join and help build the culture and success of a dynamic, independent practice and a brand new state-of-the-art clinic.
"With cutting-edge facilities and a supportive team, we want fresh expertise and energy to help shape the future of veterinary care.”
https://www.movementvets.co.uk
IMV Technologies is a reproduction biotechnology company which has worked in the field of animal artificial insemination and embryo transfer for over 50 years, with operations in more than 130 countries and subsidiaries in the USA, India, China, Italy and the Netherlands.
The newly-formed IMV Imaging now has over 500 employees, which, it says, will make it better placed to deliver the best quality ultrasound, X-ray and three-dimensional veterinary-specific imaging equipment.
The directors and senior management team from BCF and ECM are remaining to lead IMV Imaging.
Alan Picken, CEO of IMV imaging said: "The merger and creation of IMV imaging is a very exciting development for our companies. Building on our strong legacy, it allows us to deliver a wider portfolio of products and services to our customers worldwide and ultimately to deliver improved animal care.”
Using practices developed for human healthcare measurement, NewMetrica developed VetMetrica, which the company says can measure how an animal “feels” about its circumstances from its individual perspective.
Jim Brick, Vice President Commercial Development and Lifecycle and Innovation at Zoetis said: "This novel approach supports a significant shift in veterinary care and animal welfare more generally towards the attainment of good or excellent quality of life in companion animals.
"The benefits of NewMetrica’s digital instruments have been validated through scientific publications and the FDA, and the EMA has confirmed the algorithms that produce the results.”
Jamie Brannan, President International Operations, Zoetis added: "We expect NewMetrica’s tools and algorithms to support earlier detection and treatment of diseases as we gain more insight into the quality of life of our pets and be an important element of future product development.
“NewMetrica’s instruments will give us scientifically validated results for alleviation of OA pain that veterinarians and pet owners will appreciate and value.”
https://www.newmetrica.com
The statistic came to light as a result of Ceva's Mercury Challenge1, in which veterinary practices from around Europe took blood pressure readings from over 10,000 cats over seven years old, 4000 of which were from the UK.
The Challenge results, which were recently presented at Ceva Cat Expertise 2021 by the international feline medicine specialist, Dr Andy Sparkes, showed that more than 40% of cats enrolled in the Mercury Challenge were hypertensive, with a blood pressure about 30% higher than the blood pressure value found in healthy cats.
Ceva says this high percentage suggests that feline hypertension may be even more common than suspected, especially in the ageing cat population, with the mean age of hypertensive cats found to be 13 years old in the Challenge.
The study also found that up to one in three cats had both hypertension and chronic kidney disease (CKD). Feline hypertension is also associated with hyperthyroidism.
Jodie Tanner, veterinary surgeon at Lime Tree Vets in Staffordshire who participated in the Mercury Challenge said: “We were surprised by how many of the cats whose blood pressure we measured as part of the Mercury Challenge were actually hypertensive and were taken aback at the number of hypertensive cats which lacked clinical signs or target organ damage.
"These hypertensive cats would have previously gone undetected prior to us screening our older patients and they would probably have only presented when they had advanced target organ damage, such as blindness.
“Measuring blood pressure in cats is now incorporated into our bespoke preventative health care plan – The Pet Plus Membership – and our ‘Gold Plan’ is tailored to our patients over eight years of age.
"Included in the Gold Plan are twice yearly blood pressure checks, so we can pick up hypertension cases as early as possible, and the plan also includes twice yearly urine screens and yearly blood screens to pick up other common diseases seen in older cats such as hyperthyroidism and CKD.”
Ceva has a range of resources available to support veterinary practices, including those that want to set up vet nurse blood pressure clinics. There's a digital hypertension tool kit available by registering at www.easethepressure.co.uk, where you will also find information on the Hypertension CPD Hub, an Ease the Pressure pack containing resources to support vet practices, owner communications materials and information about Ceva’s online Hypertension Ambassador CPD course. A vet practice social media pack is also available.
For further information, visit www.easethepressure.co.uk or contact your local Ceva territory manager.
Reference
The plan is designed to help mimic the way cats eat in the wild and so provide them with both physical and mental stimulation. It also encourages cats to hunt, explore, climb and play – activities which boost cats’ positive behaviour and wellbeing.
Developed by feline behaviour specialist Dr. Sarah Ellis and Dr. Lizzie Rowe at International Cat Care, the plan is also designed to help to prevent overeating and promote a balance between energy intake and energy output, in order to avoid weight gain, as well as encouraging weight loss in overweight cats.
It is estimated that there are 10 million pet cats in the UK1 and the charity points to data which suggests that 39 – 52% of them are overweight or obese2,3, something which is a major health and welfare issue4-9, and can ultimately lead to early death10.
The charity says research shows that current feeding practices are contributing to this obesity epidemic, with a number of factors associated with a cat’s modern lifestyle leading to overeating. For example, most cats need little or no exertion to obtain their food, making it more likely that the calories they take in through eating will outweigh the calories they use up through exercise (leading to weight gain). Furthermore, the way we feed our cats generally does not match the lifestyle they were designed for, resulting in a lack of mental stimulation and reduced opportunity to express natural, instinctive hunting behaviours. This can lead to boredom, apathy, anxiety, frustration and stress in cats, resulting in reduced wellbeing and potentially the development of problem behaviours.
Sarah said: "By making a few simple changes to the way we feed our cats, we can help them to live longer, healthier and happier lives."
The plan recommends:
A detailed version of the feeding plan, along with the full report behind the development of the plan, can be found on International Cat Care’s website:
https://icatcare.org/advice/general-care/keeping-your-cat-healthy/feeding-your-cat-or-kitten
A short version of the feeding plan can also be found there.
Ceva says the adverts, which will air on Channel 4 and Channel 4 partner channels until 20th January, will reach 15 million people. That might prove a conservative estimate though, because the Adaptil advert on YouTube has already had over 800,000 views, whilst the Feliway advertisement has had very nearly as many.
In addition, Adaptil has partnered with The Times to support its 'Walking the Dog' podcast series hosted by radio presenter and journalist Emily Dean.
During the podcasts, Emily talks with celebrities like Noel Fitzpatrick, Jimmy Carr, Rob Bryden and Jonathan Ross as they walk their dogs. An Adaptil advert airs at the start, middle and end of each podcast.
You can hear the podcasts on itunes here: https://itunes.apple.com/gb/podcast/walking-the-dog-with-emily-dean/id1220510307
Abigail King, behaviour product manager at Ceva Animal Health said: "Our new TV advertising campaigns and podcast partnership will boost awareness of both Adaptil and Feliway throughout the festive period and into January, when changes to routine, visitors in the household and loud noises from Christmas crackers and fireworks can challenge even the most laid-back pet."
For more information, visit: www.adaptil.com or www.feliway.com.
According to the company, the new injectable form of Vetmedin provides rapid acting treatment for canine congestive heart failure originating from valvular insufficiency (e.g. mitral valve disease, MVD) or dilated cardiomyopathy (DCM). Twelve hours after the injection is administered, treatment can be continued by the dog's owner with Vetmedin flavour tablets or Vetmedin hard capsules at the recommended dosage.
Ruth Willis BVM&S DVC MRCVS, RCVS Recognised Specialist in Cardiology said: "Parenteral administration of medicines is often preferred in cases of acute congestive heart failure to help minimise patient stress and clinical deterioration. Vetmedin Solution for Injection is therefore a useful addition to our armoury of products for the treatment of acute congestive heart failure due to MVD or DCM."
The injection contains 0.75 mg/ml of the active ingredient, pimobendan, and it is supplied in 5 ml single use vials at the licensed dose of 0.15 mg/kg, with one vial treating a dog up to 25 kg.
In association with the Vets Now emergency treatment service, Boehringer has produced an algorithm which features step-by-step guidance on the recommended treatment protocol for dogs with acute congestive heart failure due to MVD or DCM, together with point of sale material including shelf wobblers for use in practice to raise awareness of the product.
The company is also hosting a free cardiology webinar presented by Ruth Willis entitled 'Acute CHF - a stress free approach'. The online seminar takes place at 8.00pm on Tuesday 19 February and counts for one hour's CPD. The webinar will be available to view after the live event on demand. To register, visit http://www.bi-academy.co.uk/.
For further information, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
According to a report in the Daily Mail, Worcester vet David Denny MRCVS accidentally euthanised a Jack Russell in the presence of its owner, who believed he was giving the animal antibiotics.
Mr Denny told VetSurgeon.org that it had been the result of a dreadful misunderstanding between himself and his secretary, for which he had apologised, but that he couldn't say much more because the VDS had advised him not to talk to the media.
The dog, called Gunner, was 14 years old; old enough that alarm bells obviously didn't go off when it was presented to Mr Denny for euthanasia (or so he thought).
The story does serve as a reminder of the importance of communicating with absolute clarity, both written and oral, when performing euthanasia. In this case, the Daily Mail reports that Mr Denny asked the client: "if Gunner had had enough". Under any other circumstances, that would seem a sensitive comment to make. In this case, though, the owner thought he meant the dog had had enough of its cough.
The study “Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom” used the Small Animal Veterinary Surveillance Network to review electronic health records equating to 3,150,713 consultations (917,373 dogs) from 224 veterinary practices2.
Five hundred and seventeen cases were included. Dogs older than 6 years were excluded.
Of 321 dogs presented for a single seizure, seven (2.1%) were prescribed AEDs, which is in accordance with International Veterinary Epilepsy Task Force recommendations.
20% of the dogs in this group which had at least a 6-month follow-up, 20% did not have subsequent seizures recorded.
However, of 86 dogs which had suffered a seizure cluster at first presentation, only 38 (44%) were prescribe an AED, despite the task force recommendation that long term treatment in dogs with idiopathic epilepsy should be started immediately in the case of 2 or more seizures within 6 months, status epilepticus or a seizure cluster, severe post-ictal signs, or a deteriorating epileptic presentation.
Imepitoin was frequently selected in the treatment of cluster seizures despite no authorisation for this purpose.
Nicola Di Girolamo, Editor of JSAP said: “Studies like this one are instrumental to understand how primary care clinicians comply with current recommendations.
"Additional efforts may be required to fully adhere to the International Veterinary Epilepsy Task Force recommendations; being aware of these gaps is the first step towards improvement.”
Established over 100 years ago, Alfreton Park Veterinary Hospital is based in a purpose-built clinic; one of four International Society of Feline Medicine (ISFM) recognised Cat Friendly Practices in Derbyshire.
Dr Nick Pine MA VetMB MRCVS has been at Alfreton Park since 1999 and has become a Medivet Branch Partner following the acquisition, together with his colleague Dr Matt Ingram CertSAS MRCVS. He said: "We are excited about joining the Medivet Partnership. It will help us to continue to develop what is an already successful, trusted and highly respected local practice and enable us to offer even more opportunities for our people."
Medivet Chief Executive Officer Dr Arnold Levy, said: "Alfreton Park is an impressive practice with a great team and we are delighted to welcome them to Medivet. Our model is focused on adding value to every practice that joins our partnership, and we look forward to working with Nick and Matt to build an even brighter future for the practice, its clients and patients."
The survey was promoted to the profession via the websites, by Veterinary Times and through the RCVS Mind Matters newsletter. The data was then anonymised, analysed and reported on by Sally Everitt MRCVS, ex Head of Scientific Policy at BSAVA.
677 participants reported being on the receiving end - within the last year - of at least one of 15 types of unpleasant behaviour which ranged from being physically intimidated through to being on the receiving end of sly glances. However, on average, each respondent experienced no less than five different types of unpleasant behaviour.
Of these, 390 were veterinary nurses, 252 were veterinary surgeons and 13 were practice managers.
The most frequently reported behaviours were: 'being belittled in front of other staff' (73%), 'being criticised minutely, repeatedly and seemingly unfairly' (65%), 'being aware of management or senior staff talking negatively about you behind your back' (51%), and '‘having your authority undermined to others in the practice, for example by having your instructions countermanded commonly and without consultation' (50%).
Seen in isolation, some might question whether these sorts of behaviour amount to bullying. It is important therefore to stress both that they typically formed part of a pattern of behaviour (the five different behaviour types reported, on average, by each respondent), and that the survey specifically asked only for reports where the behaviour was repeated.
Separately, 344 people also said they were currently on the receiving end of sustained patterns of behaviour, usually from one person, which seemed designed to make their life unpleasant.
Respondents were also invited to describe in more detail how they felt they had been mistreated at their practice.
Sally said: "Reading the responses, four main themes stood out: not feeling part of the team, lack of respect, lack of support and issues around management including not being listened to and perceptions of being treated unfairly."
Participants in the survey were then asked to describe what impact the behaviour had on their working life.
Sally said: "The answers to this question often demonstrated that the respondents had been very upset by the behaviours. Of the 560 replies to this question, 220 described an impact on their mental health, from anxiety to breakdowns and suicidal thoughts. 120 respondents talked specifically about the impact on their lack or loss of confidence, and 207 talked about leaving their job or the profession entirely."
Survey participants were then asked what they planned to do about it. Out of 680 replies, 195 talked about moving practice as soon as they can, 164 said they would take it up with the practice manager (however, of the 55 who reported this in the free text answer, 30 said it led to no change or made things worse), and 109 said they had no choice but to suffer in silence. 45 said they had or would leave the profession and only 35 said they would take it up with the perpetrator themselves.
As regards who is bullying who, more or less the same number of people reported being bullied by a veterinary surgeon as a veterinary nurse. What was interesting, and important for those in positions of leadership to note, is that veterinary nurses were much more likely to be bullied by other nurses and vets by other vets.
Finally, respondents were asked a series of questions about whether there was a zero tolerance of bullying or conflict resolution policy in force and enforced at their practice. Only 24 and 28% of respondents respectively were aware of such policies being in place. What was also clear was that having such policies and enforcing them correlated with lower levels of being on the receiving end of sustained patterns of unpleasant behaviour at the practice.
Arlo Guthrie, Editor of VetSurgeon.org and VetNurse.co.uk said: “Above all else, I want to thank everyone who shared their experience so that others can draw comfort in knowing they are by no means alone in this. I also want you to know that you’ve been heard.
"Given the survey design, it is not possible to draw any conclusions concerning the prevalence of bullying in the veterinary profession. What we can say for sure is that there have been 680 reports. If, as the data indicates, these are from different practices, then it is something that goes on in a significant proportion of veterinary practices."
"The million dollar question is what needs to be done next. It seems to me that the first and most important thing is that the profession needs to talk about behaviour and its impact openly and candidly, mirroring the great strides forward in the area of mental health."
In addition, the survey report proposes further discussion - at both a practice and professional organisation level - about things which:
As one veterinary nurse commented: "Pay is obviously important when you have a mortgage and bills, but not dreading going into work every day, it’s priceless!"
To download the report in full, click the link below:
PDF
A new range of food flavour sprays for dogs and cats, which could it a lot easier for vets, nurses and owners to feed reluctant eaters and administer oral medications, has been launched by M H Foods Ltd.
The sprays, which will retail through veterinary practices only, are primarily designed to encourage cats and dogs to eat in situations where they are reluctant to feed.
Testimonials received by the company from vets and veterinary hospitals suggest the sprays may help pets to eat when recovering from surgery or suffering from anxiety or depression. The company says they have also been helpful in encouraging pets to eat before their insulin injections and to enjoy bland foods such as renal diets.
Fred Key, Managing Director of M H Foods, said: "The well-researched aromas and flavours of this patented development, which we have branded Bon Appetit, entice pets back to eating. Another plus, pointed out by veterinary nurses, is that our flavour sprays disguise tablets and medication powder on food, making life easier for pets and owners alike!
"The Bon Appetit range - in chicken, beef and fish varieties - is artificially flavoured and, therefore, has no protein and is free from sodium, potassium and phosphorous, adding only 2 Cals per spray".
Retailing at around £5 to £6 for about 50 days' supply, M H Foods says that Bon Appetit has been well received by the major veterinary wholesalers.
Testimonials, full product and analytical information is available at: http://www.mh-foods.co.uk/.
European Specialist in Veterinary Dentistry Lisa Milella has revealed in an interview with the Sunday People that she has been diagnosed with motor neurone disease, a condition which few people survive for more than 2-5 years.
It's hard to imagine anything much worse than being told in advance when your appointment with the Grim Reaper is booked, and for many the temptation might be just to give up there and then. Not Lisa. She embarked on the most extraordinary mission to fulfill ten of her life's ambitions.
The day after her diagnosis last August, she closed her veterinary practice in Byfleet. In December, she went sledging with huskies in Norway. In January, she flew to Borneo to carry out dental surgery on an orangutan. Three days later, she visited International Animal Rescue in Java and trained vets there to carry out dental work on slow lorises. She then celebrated her 40th birthday surrounded by friends and family in February. In May, she headed out to Peru to visit the Inca trail and the Amazon rainforest. From there, it was on to the Galapagos Islands. Then last week she went to India, where she trained another team to perform dental surgery on bears, and fulfil the 8th and 9th ambitions on her list, which were to operate on a leopard and a tiger.
Lisa closed her interview in the Sunday People saying: "I'm never going to get better and today is as strong as I'm ever going to be. You've got to make the most of now and not worry about tomorrow. Go out there and do it. You're never going to have that time again."
Oh. One other thing. Lisa's 10th wish was to get 100 strangers to donate £100 to International Animal Rescue. I hope you'll join me: https://www.justgiving.com/Lisa-Milella-100/
Researchers studied 840 patients with breast, prostate, lung or colorectal cancer. 280 patients that had received only alternative medicine were matched to 560 control patients who chose conventional cancer therapy.
Overall, cancer patients who used alternative medicine were 2.5 times more likely to die within a 5 year period than those who chose conventional cancer therapy.
However, people with breast cancer were 5.7 times more likely to die in the same period if they used alternative medicine rather than conventional medicine.
This evidence flies in the face of the British Association of Veterinary Homeopathic Veterinary Surgeons' claim that homeopathy cures cancer.
But more importantly, one of the main reasons why practitioners in both human and veterinary medicine so often acquiesce to their patients' use of alternative medicine is because of the perception that they do no harm. After all, homeopathy is only water, right?
This study provides perhaps the first evidence that the reverse may be true. That if you do not actively deter clients from using discredited forms of alternative medicine, you may be allowing them to sentence themselves, or rather their dog, to an early death.
The referral centre recently extended its floor space at its base in Cheshire to support a major expansion of the services being offered, which include orthopaedic, soft tissue and spinal surgery and internal medicine; with specialist support in anaesthesia and pain management, a diabetes clinic, intensive care, cardiology, diagnostic imaging, neurology (medical and surgical) and oncology.
Liz Cousins, hospital manager at Northwest Veterinary Specialists, said: "The success of NWVS is down to the dedication of our highly skilled clinical, nursing and support teams.
"Our clinicians are well respected specialists in their chosen disciplines and it’s fantastic to be able to offer new services to pets and first opinion vets.
"The hospital is home to 88 colleagues and the change of name now reflects the growth and dedication by everyone here at Northwest Veterinary Specialists since opening in 2002."
Northwest Veterinary Specialists provides specialist veterinary services to veterinary practices in north west England and north and mid Wales.
Liz added: "At Northwest Veterinary Specialists we treat pets from as far apart as Carlisle, North Yorkshire and Staffordshire.
"The facilities are state-of-the-art, demonstrating a quality of service both for our clinicians and our clients, but most importantly the pets that we treat."
The new rules will make it illegal to sell puppies younger than eight weeks and require anyone breeding and selling three or more litters of puppies a year to apply for a formal licence.
Those needing a licence, including online sellers, will also be required to display their permit in any advertising, and to give owners information about the five welfare needs that owners must meet under the Animal Welfare Act.
The penalty for breaking the new law will be an unlimited fine and/or up to six months in prison.
The plans also cover how pet shops, boarding houses and riding stables are licensed, introducing a single 'animal activities licence' to improve the process and make enforcement easier.
Environment Secretary Andrea Leadsom said: "Everyone who owns a pet or is looking to introduce one into their life will want to know that the animal has had the very best start to life. Yet for thousands of puppies born each year to irresponsible breeders, from smaller operations to larger puppy farms, their first weeks are spent in cramped and squalid conditions without the care and attention they need. That is why we are cracking down on the worst offenders by strengthening the dog breeding licence and giving councils the power they need to take action.
With more and more pet sales now taking place on the internet, it’s right that this market is subject to the same strict licensing criteria as other breeders and pet shops so that consumers are not misled. The plans announced today will help people choosing new family pets to be confident the animals have been properly bred and cared for from birth and are ready to move safely to their new homes.
Gudrun Ravetz, President of the British Veterinary Association, said: "This is a significant step in the right direction to improve the welfare of puppies and dogs in the UK, an issue our members are extremely concerned about as increasing numbers of poorly bred puppies are brought into veterinary practices.
"Poorly bred and badly socialised puppies cause terrible health and welfare problems for dogs so it is right that Defra has made irresponsible dog breeding a priority. We particularly welcome the move to make the sale of a puppy under eight weeks illegal, the reduction in the number of litters bred requiring a formal breeder’s licence, and the moves towards a single animal activities licence. In the future we would also like to see that anyone breeding from a dog should be required to register with their local authority.
"For these new measures to work in practice local authorities must have the necessary resources and support to fully enforce the legislation, supported by local veterinary expertise.
"We hope the new legislation will encourage owners to stop and think about where they’re getting their puppies from to tackle irresponsible breeding both at home and abroad. Prospective owners should do their homework and always use the puppy contract and information pack to make sure they ask breeders the right questions for a happy, healthy puppy."
The Kennel Club and Dogs Trust have welcomed the announcement.
Dogs Trust Veterinary Director, Paula Boyden said: "As the UK’s largest dog welfare charity, Dogs Trust welcomes the Government’s review of animal establishments licensing in England and the range of measures it sets out.
"We are particularly pleased that it will be illegal to sell a puppy below the age of 8 weeks and that there will be tighter licensing rules which will require sellers of pets to display their licence when advertising. We also applaud the move towards a risk based single licensing system which will incorporate those breeders that have gained UKAS approval rather than exempting them.
We believe that Local Authority Inspectors need support to enforce these tighter licensing rules. As such, moves to mandate the use of Model Conditions and for inspectors to be offered training and standards to be set is most welcome."